Basics |
Company: |
ACADIA Pharmaceuticals Inc. |
IPO Date: |
June 1, 2004 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$3.33B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.44 | 2.69%
|
Avg Daily Range (30 D): |
$0.37 | 1.99%
|
Avg Daily Range (90 D): |
$0.32 | 1.87%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.19M |
Avg Daily Volume (30 D): |
2.11M |
Avg Daily Volume (90 D): |
1.48M |
Trade Size |
Avg Trade Size (Sh.): |
134 |
Avg Trade Size (Sh.) (30 D): |
88 |
Avg Trade Size (Sh.) (90 D): |
79 |
Institutional Trades |
Total Inst.Trades: |
9,438 |
Avg Inst. Trade: |
$2.22M |
Avg Inst. Trade (30 D): |
$7.67M |
Avg Inst. Trade (90 D): |
$5.82M |
Avg Inst. Trade Volume: |
.09M |
Avg Inst. Trades (Per Day): |
3 |
Market Closing Trades |
Avg Closing Trade: |
$3.99M |
Avg Closing Trade (30 D): |
$12.94M |
Avg Closing Trade (90 D): |
$7.36M |
Avg Closing Volume: |
163.45K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$.78
|
$.2
|
$.2
|
Diluted EPS
|
$.78
|
$.2
|
$.2
|
Revenue
|
$ 929.24M
|
$ 250.4M
|
$ 241.96M
|
Gross Profit
|
$ 851.31M
|
$ 231.54M
|
$ 223.73M
|
Net Income / Loss
|
$ 128.51M
|
$ 32.77M
|
$ 33.39M
|
Operating Income / Loss
|
$ 112.24M
|
$ 31.64M
|
$ 30.44M
|
Cost of Revenue
|
$ 77.93M
|
$ 18.86M
|
$ 18.23M
|
Net Cash Flow
|
$ 60M
|
$ -18.94M
|
$ -27.61M
|
PE Ratio
|
25.69
|
|
|
|